Occlusion of the perimembranous ventricular septal defect using CERA® devices

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 2, 2012, Pages 182-187

  Esteves, Cesar A ^a,b   Solarewicz, Leo A ^c   Cassar, Renata ^d   Neves, Juliana R ^d   Esteves, Vinicius ^b   Arrieta, Raul ^d  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^c HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^d INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

congenital heart disease; congenital septal defect; percutaneous intervention

Indexed keywords

ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; AORTA VALVE REGURGITATION; ARTICLE; CHILD; COMPLETE HEART BLOCK; CONGENITAL HEART DISEASE; DIASTOLE; DISEASE SEVERITY; FEMALE; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE VOLUME; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PATIENT MONITORING; PERIMEMBRANOUS VENTRICULAR SEPTAL DEFECT; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEPTAL OCCLUDER; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 85027944665     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24371     Document Type: Article

References (10)

1. Hijazi Z, Hakim F, Haweleh AA, Madani A, Tarawna H, Hiari A, Cao QL,. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv 2002; 56: 508-515. (Pubitemid 34809032)
2. Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanopoulos BD, Torres W, Sievert H, Carminati M, Fisher G, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003; 58: 238-245. (Pubitemid 36159571)
3. Pedra CA, Pedra SRF, Esteves CA, Pontes SC, Braga SL, Arrieta SR, Santana MV, Fontes VF, Masura J,. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: Technical and morphological considerations. Catheter Cardiovasc Interv 2004; 61: 403-410. (Pubitemid 38298282)
4. Yun-Ching Fu, Bass J, Amin Z, et al. Transcatheter Closure of Perimembranous Ventricular Septal Defects Using the New Amplatzer Membranous VSD Occluder. Results of the U.S. Phase I Trial. J Am Coll Cardiol 2006; 47: 319-325. (Pubitemid 43063248)
5. Butera G, Chessa M, Carminati M,. Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect. Catheter Cardiovasc Interv 2006; 67: 938-941. (Pubitemid 43837080)
6. Chessa M, Butera G, Negura D, Bussadori C, Giamberti A, Fesslova V, Carminati M,. Transcatheter closure of congenital ventricular septal defects in adult: Mid-term results and complications. Int J Cardiol 2009; 133: 70-73.
7. Lillehei CW, Cohen M, Warden HE, Varco RL,. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Urg Gynecol Obstet 1955; 101: 447.
8. Lock JE, Block PC, McKay RG, Baim DS, Keane JF,. Transcatheter closure of ventricular septal defects. Circulation 1988; 78: 361-368.
9. Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, Peuster M, Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K,. Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J 2007; 28: 2361-2368. (Pubitemid 47537785)
10. Lifeng Z, Yan H, Dayun Y, Xiaoying L, Tingfei X, Deyuan Z, Ying H, Jinfeng Y,. The underlying biological mechanisms of biocompatibility differences between bare and TiN-coated NiTi alloys. Biomed Mater 2011; 6: 1-12.